ReachMD

Episodes 1-15 of 27

• • 

    

    Sagar Lonial, MD

    Peer

  • 

    

    Noopur Raje, MD

    Peer

  0

  

  RestartResume

  Novel Clinical Approaches in Multiple Myeloma: CAR T Cell Therapy

  Novel Clinical Approaches in Multiple Myeloma: CAR T Cell Therapy

  0.25 credits

• • 

    

    Lyudmila Bazhenova, MD

    Peer

  • 

    

    Benjamin Levy, MD

    Peer

  2

  

  RestartResume

  The Emerging Role of HER2 (ERBB2) Mutations in NSCLC

  The Emerging Role of HER2 (ERBB2) Mutations in NSCLC

  0.25 credits

• • 

    

    Amer Zeidan, MBBS

    Peer

  • 

    

    Amy E. DeZern, MD, MHS

    Peer

  0

  

  RestartResume

  Managing and Monitoring MDS: MDS-Related Effects and Progression to AML

  Managing and Monitoring MDS: MDS-Related Effects and Progression to AML

  0.25 credits

• • 

    

    Andrew M. Brunner, MD

    Peer

  • 

    

    Amy E. DeZern, MD, MHS

    Peer

  1

  

  RestartResume

  A New Light in Higher-Risk MDS: Emerging Treatment Options

  A New Light in Higher-Risk MDS: Emerging Treatment Options

  0.25 credits

• • 

    

    Jacqueline Garcia, MD

    Peer

  • 

    

    David A. Sallman, MD

    Peer

  1

  

  RestartResume

  Keeping Pace with Hematologic Malignancies: Understanding, Classifying, and Stratifying MDS

  Keeping Pace with Hematologic Malignancies: Understanding, Classifying, and Stratifying MDS

  0.25 credits

• • 

    

    Larry Anderson, MD, PhD

    Peer

  • 

    

    Thomas G. Martin, MD

    Peer

  2

  

  RestartResume

  State of the Union: CAR T Cell Therapy

  State of the Union: CAR T Cell Therapy

  0.25 credits

• • 

    

    Scott Kopetz, MD, PhD

    Peer

  • 

    

    Elena Elez, MD, PhD

    Peer

  • 

    

    Elizabeth Smyth, MD

    Peer

  0

  

  RestartResume

  Clarifying the Value of Anti-EGFR Therapy in Metastatic Colorectal Cancer

  Clarifying the Value of Anti-EGFR Therapy in Metastatic Colorectal Cancer

  0.25 credits

• • 

    

    Mark Socinski, MD

    Peer

  • 

    

    Vivek Subbiah, MD

    Peer

  2

  

  RestartResume

  Keeping Pace in Lung Cancer: Improving Outcomes for Patients with RET-Positive NSCLC

  Keeping Pace in Lung Cancer: Improving Outcomes for Patients with RET-Positive NSCLC

  0.25 credits

• • 

    

    Mark Socinski, MD

    Peer

  • 

    

    Sandip Patel, MD

    Peer

  1

  

  RestartResume

  Keeping Pace in Lung Cancer: Integration of Immune Checkpoint Inhibitors as Initial Therapy for Advanced Disease

  Keeping Pace in Lung Cancer: Integration of Immune Checkpoint Inhibitors as Initial Therapy for Advanced Disease

  0.25 credits

• • 

    

    Mark Socinski, MD

    Peer

  • 

    

    Benjamin Levy, MD

    Peer

  0

  

  RestartResume

  Keeping Pace in Lung Cancer: Clinical Case Challenges in NSCLC

  Keeping Pace in Lung Cancer: Clinical Case Challenges in NSCLC

  0.25 credits

• • 

    

    Mark Socinski, MD

    Peer

  • 

    

    Edward B. Garon, MD, MS

    Peer

  3

  

  RestartResume

  Keeping Pace in Lung Cancer: Guidelines and the Future Direction of Immunotherapy in NSCLC

  Keeping Pace in Lung Cancer: Guidelines and the Future Direction of Immunotherapy in NSCLC

  0.25 credits

• • 

    

    Joël Guigay, MD, PhD

    Peer

  • 

    

    Kevin J. Harrington, MD

    Peer

  2

  

  RestartResume

  Unravel Global Clinical Complexities in Head and Neck Cancers: Identifying Approaches to Improve Outcomes with Manageable Toxicities

  Unravel Global Clinical Complexities in Head and Neck Cancers: Identifying Approaches to Improve Outcomes with Manageable Toxicities

  0.25 credits

• • 

    

    Daniel P. Petrylak, MD

    Peer

  • 

    

    Arlene O. Siefker-Radtke, MD

    Peer

  4

  

  RestartResume

  Keeping Pace in Bladder Cancers: All About Sequencing in Locally Advanced or Metastatic Urothelial Carcinoma

  Keeping Pace in Bladder Cancers: All About Sequencing in Locally Advanced or Metastatic Urothelial Carcinoma

  0.25 credits

• • 

    

    Mark Socinski, MD

    Peer

  • 

    

    Justin Gainor, MD

    Peer

  2

  

  RestartResume

  Keeping Pace in Lung Cancer: Applying the Right Therapy to the Right Patient in RET-Positive NSCLC

  Keeping Pace in Lung Cancer: Applying the Right Therapy to the Right Patient in RET-Positive NSCLC

  0.25 credits

• • 

    

    Lauren Ritterhouse, MD ,PhD

    Peer

  • 

    

    Pasi Antero Jänne, MD, PhD

    Peer

  • 

    

    Kanwal Raghav, MD

    Peer

  1

  

  RestartResume

  The Role of HER3 Expression in Advanced Solid Tumors

  The Role of HER3 Expression in Advanced Solid Tumors

  0.50 credits

• 1
• 2
• Next